A confirmation study of the immunostimulating effect of beekeeping products intake in healthy subjects
- Conditions
- Adult
- Registration Number
- JPRN-UMIN000050822
- Lead Sponsor
- Yamada Bee Company, Inc.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 64
Not provided
1) Persons with a blood glucose level of 140 mg/dl or higher at any time two hours after a meal at the time of screening 2) Those who are continuously taking dietary supplements or supplements related to immune enhancement 3) Persons with allergic diseases such as rhinitis or atopy 4) Those who work day and night shifts or engage in physical labor such as heavy lifting 5) Those who engage in strenuous exercise (6Mets or more) for more than 3.5 hours per week. 6) Subjects who are undergoing treatment that may affect the study, such as hyposensitization therapy. 7) Subjects with a disease under treatment or a history of a serious disease 8) Patients with a history of food allergy 9) Subjects who are judged to be unsuitable for the study based on the results of the SCR examination or the questionnaire at the time of application for the study. 10) Pregnant or lactating women or those who wish to become pregnant during the study period 11) Subjects who are participating or will participate in other clinical trials within one month of obtaining consent for this study. 12) Persons who are unable to comply with administrative requirements during the study period 13) Persons who smoke (including electronic cigarettes) 14) Persons who are unable to comply with instructions to wear a mask when visiting the clinic 15) Persons who have fever or other cold symptoms or taste or smell disorders within one week of each observation point 16) Persons with a history of contact with COVID-19 patients or persons in close contact with COVID-19 patients within 2 weeks of each observation point 17) Persons who have traveled to foreign countries or had contact with such persons within 2 weeks of each observation point. 18) Any other person who is judged by the investigator to be inappropriate to participate in this study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method K cells activity
- Secondary Outcome Measures
Name Time Method